eTheRNA immunotherapies conference attendance from December 2021 to March 2022
eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, will be attending the following conferences from December 2021 to March 2022:
BioFIT Digital
7-9 December 2021
Tim Van Assche, VP of Business Development and Alliance will be in attendance.
ESMO Immuno-Oncology Online Congress
8-11 December 2021
Marina Cools, VP of Clinical Development will be in attendance.
Kempen Life Sciences Crossover Conference
6 January 2022
Steven Powell, Chief Executive Officer, and Mathieu Lane, Chief Financial Officer of eTheRNA Inc., will be in attendance.
Biotech Showcase
10-12 January 2022
Steven Powell, Chief Executive Officer, and Mathieu Lane, Chief Financial Officer of eTheRNA Inc., will be in attendance.
